Author
1. Leier Carl V
2. Haas Garrie J
3. Binkley Philip F
ISBN
9789350252758
DOI
10.5005/jp/books/11124_6
Edition
1/e
Publishing Year
2013
Pages
15
Author Affiliations
1.
Davis heart Lung research Institute, Th e Ohio State University of Medicine and public health, Columbus, Ohio, USA,
Davis Heart Lung Research Institute, The Ohio State University of Medicine and Public Health, Columbus, Ohio, USA,
The Ohio State University College of Medicine, Columbus, Ohio, USA
2.
Davis heart and Lung research Institute, The Ohio State University of Medicine and public health, Columbus, Ohio, USA,
Davis Heart Lung Research Institute, The Ohio State University of Medicine and Public Health, Columbus, Ohio, USA,
The Ohio State University of Medicine and Public Health, Davis Heart and Lung Research Institute, Columbus, Ohio, USA
3.
The Ohio State University, Columbus, Ohio, USA,
Davis Heart Lung Research Institute, The Ohio State University of Medicine and Public Health, Columbus, Ohio, USA,
Davis Heart and Lung Research Institute, The Ohio State University of Medicine and Public Health, Columbus, Ohio, USA
Chapter keywords
Positive inotropic drugs,
adrenergic receptor agonists,
short-term positive inotropic therapy,
beta-adrenergic receptor,
cardiovascular effects,
dobutamine,
short-term inotropic support,
beta-receptor stimulation,
ventricular systolic dysfunction,
pulmonary vascular resistance,
phosphodiesterase inhibitor,
tachycardia,
isoproterenol,
dysrhythmias,
milrinone,
norepinephrine,
epinephrine,
calcium sensitizers,
levosimendan,
myocardial contractility,
digitalis-digoxin,
istaroxime,
chronic digoxin therapy,
beta-blocker therapy,
spironolactone,
atrioventricular nodal cells,
amiodarone,
kaolin-pectin
